Learning opportunity: Continuing medical education activities are required in order for physicians to maintain licensing. Rarely do we patients get exposure to their learning materials. CLL Society has partnered with Clinical Care Options to develop an educational activity for healthcare providers who treat patients with CLL. This program features expert insight commentaries, an Interactive Treatment Decision Support Tool, and a series of micro-learning, micro-education modules. Not only will it help improve CLL care offered by healthcare providers, it can also help empower and engage patients to become informed participants in shared decision-making. Have a look around the CLL sections. Explore at your own pace. Learn more about "Optimizing Decision-Making in CLL in an Era of Novel Agents," and consider sharing with your healthcare providers. clinicaloptions.com/oncolog...
Learning opportunity: "Optimizing Decision-Mak... - CLL Support
Learning opportunity: "Optimizing Decision-Making in CLL in an Era of Novel Agents"/ What doctors are learning about treating CLL
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
1 Reply
•
Thanks Brian, education is definitely the best tool in the box for all of us with difficult decisions to make.
Not what you're looking for?
You may also like...
Resistance-Associated Mutations in CLL Patients Treated With Novel Agents
acquired resistance mechanisms to novel agents.
In 80% of patients with ibrutinib failure, acquired...
Help the CLL Society find out what CLL patients & caregivers know and still \"yearn to learn\" about MRD testing + Limited Duration Therapies
CLL Society 2020 Patient Survey: Help the CLL Society find out what our CLL patients and their...
Is It Time to Treat Your CLL? What You Need to Know
Susan O’Brien, will review key decision-making factors, current CLL treatments and emerging...
What occurs if I don’t treat CLL?
my body if I simply refuse treatment.
Can anyone share what may be in store? Is there any...